Particle Data Platform

Rethinking GLP-1 Medications

12:4513:15 · 31s

Dr. Moskovitz recounts her shift from outright skepticism to cautious approval of GLP-1 weight-loss drugs, cautioning listeners about how intoxicating the rapid results can feel and stressing the need for professional oversight.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.